Brain Involvement in Neuromyelitis Optica Spectrum Disorders

被引:85
|
作者
Chan, Koon Ho [1 ,2 ,3 ]
Tse, C. T. [1 ]
Chung, C. P. [1 ]
Lee, Raymand L. C. [1 ]
Kwan, J. S. C. [1 ,2 ]
Ho, P. W. L. [1 ,3 ]
Ho, J. W. M. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Neuroimmunol & Neuroinflammat Res Lab, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
INFLAMMATORY DEMYELINATING DISORDERS; RESONANCE-IMAGING ABNORMALITIES; ANTI-AQUAPORIN-4; ANTIBODY; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; WATER CHANNEL; IGG; NMO; RITUXIMAB;
D O I
10.1001/archneurol.2011.249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuromyelitis optica spectrum disorders (NMOSDs) are severe inflammatory demyelinating disorders of the central nervous system. Brain involvement is increasingly recognized. Objective: To study brain involvement in NMOSDs among Hong Kong Chinese patients. Design: Retrospective study of patients with NMOSDs. Setting: Tertiary medical center in Hong Kong. Patients: Thirty-four Hong Kong Chinese patients with NMOSDs of 2 years or longer were recruited. Interventions: Brain and spinal cord magnetic resonance imaging was performed during NMOSD attacks and was repeated yearly for the first 3 years. Main Outcome Measures: We evaluated clinical features of NMOSDs associated with brain involvement and brain lesions on magnetic resonance imaging. Results: Among 34 patients with NMOSDs of 2 years or longer, 20 (59%) had brain involvement. The mean age at onset among these 20 patients was 45.6 years (age range, 19-67 years); 18 were women. Eleven patients (32% of all the patients with NMOSDs) had clinical manifestation of brain involvement, 19 patients (56%) had brain abnormalities on magnetic resonance imaging consistent with inflammatory demyelination, and 2 patients (6%) fulfilled criteria for multiple sclerosis. Clinical manifestation of brain involvement included the following: trigeminal neuralgia; vomiting, vertigo, ataxia, dysphagia, and tetraparesis from lesions around the third and fourth ventricles and aqueduct; homonymous hemianopia, aphasia, hemiparesis, and cognitive impairment from extensive hemispheric white matter lesions; and ataxia, diplopia, hiccups, facial sensory loss, internuclear ophthalmoplegia, hemisensory loss, and hemiparesis from other lesions in the midbrain, pons, cerebellar peduncles, and medulla. Eight patients (24%) developed brainstem encephalitis clinically, and brainstem encephalitis was the initial clinical manifestation in 6 patients (18%). Brain abnormalities on magnetic resonance imaging were detected in brainstem in 15 patients (44%), hemispheric periventricular white matter in 7 patients (21%), deep white matter in 7 patients (21%), corpus callosum in 4 patients (12%), subcortical white matter in 3 patients (9%), thalamus in 2 patients (6%), hypothalamus in 1 patient (3%), basal ganglia in 1 patient (3%), internal capsule in 1 patient (3%), periaqueductal gray matter in 1 patient (3%), and around the third and fourth ventricles in 1 patient (3%); large confluent lesions were detected in 2 patients (6%). Conclusion: Brain involvement manifesting clinically as brainstem encephalitis is common among Hong Kong Chinese patients with NMOSDs.
引用
收藏
页码:1432 / 1439
页数:8
相关论文
共 50 条
  • [1] Neuromyelitis optica and neuromyelitis optica spectrum disorders
    Marignier, Romain
    Calvo, Alvaro Cobo
    Vukusic, Sandra
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 208 - 215
  • [2] The pathology of brain involvement in neuromyelitis optica spectrum disorder
    Jacobs, D.
    Roemer, S.
    Weinshenker, B.
    Pittock, S.
    Wingerchuk, D.
    Lennon, V.
    Lucchinetti, C. F.
    MULTIPLE SCLEROSIS, 2006, 12 : S155 - S155
  • [3] Spectrum of Neuromyelitis optica spectrum disorders
    Khan, F. M.
    Dave, D.
    Rao, P.
    Nirhale, S.
    Rohatgi, S.
    Naphade, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 685 - 685
  • [4] Neuromyelitis Optica Spectrum Disorders
    Eoin P. Flanagan
    Brian G. Weinshenker
    Current Neurology and Neuroscience Reports, 2014, 14
  • [5] Neuromyelitis Optica Spectrum Disorders
    Akaishi, Tetsuya
    Nakashima, Ichiro
    Sato, Douglas Kazutoshi
    Takahashi, Toshiyuki
    Fujihara, Kazuo
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2017, 27 (02) : 251 - +
  • [6] Neuromyelitis Optica Spectrum Disorders
    Flanagan, Eoin P.
    Weinshenker, Brian G.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (09)
  • [7] Intractable Pruritus in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
    Xiao, L.
    Qiu, W.
    Lu, Z.
    Li, R.
    Hu, X.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 662 - 663
  • [8] Neuromyelitis optica spectrum disorders
    Paul, Shabeer
    Mondal, Gouranga Prasad
    Bhattacharyya, Ramesh
    Ghosh, Kartik Chandra
    Bhat, Imtiyaz Ahmad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 420
  • [9] Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
    Ramanathan, Ramnath Santosh
    Malhotra, Konark
    Scott, Thomas
    BMC NEUROLOGY, 2014, 14
  • [10] Neuromyelitis optica spectrum disorders
    Huda, Saif
    Whittam, Dan
    Bhojak, Maneesh
    Chamberlain, Jayne
    Noonan, Carmel
    Jacob, Anu
    CLINICAL MEDICINE, 2019, 19 (02) : 169 - 176